Cipher Pharmaceuticals Inc. (CPH.TO) Deep Dive Video
Summary
Cipher is rapidly evolving from a passive royalty collector into a high‑margin North American specialty pharma operator—powered by Natroba, disciplined deleveraging, and an undervalued cash‑generative platform.